Agoracom Blog Home

Archive for the ‘Enertopia’ Category

Enertopia Provides Footage of Planned MMPR Facility

Posted by AGORACOM-JC at 9:59 AM on Thursday, November 20th, 2014

Whitefish, MT / November 20, 2014 / Thus far there has only been a handful of companies approved by Health Canada for the MMPR program, including Tweed Inc. (TSX-V: TWD) and Organigram Inc. (TSX-V: OGI), while a number of other companies, such as Abattis Bioceuticals (OTC: ATTBF) continue to await their approvals from Health Canada.

While many publicly traded companies have been talking up their plans of becoming licensed producers, few have been very open about showing off their actual facilities and demonstrating how operations will work. Outdoor images of large warehouses and pictures of land from a mile high provide investors with very little information about what’s actually happening in these companies.

Enertopia Corp. (OTC: ENRT) recently released a four part video series in conjunction with its joint venture with The Green Canvas Ltd. After signing a joint venture agreement in February of 2014, the company has begun building and outfitting a 30,000 square foot facility – scalable to 55,000 square feet – to become compliant with Health Canada’s MMPR standards.

The video tour of the planned facility includes everything from the initial clone rooms, perimeter security, vegetative grow areas, vaults, multiple staging areas for flowering, and the lights that will be used for production.

In the overall 4 part video series, Enertopia’s management team discusses its operational plans within Canada’s rapidly growing medical marijuana industry, while also interviewing current medical marijuana patients that have been treated with the utmost compassion by Green Canvas. The Green Canvas’ history as a licensed producer under the legacy Medical Marijuana Access Regulations (“MMAR”) program also provides them with the ability to show actual current growing operations.

It is the expertise of these current operations that deserves special notice. On November 8th, 2014 the invite only Karma Cup was held to determine the best flowering varieties of marijuana for the indica, sativa, and hybrid entrants. With more than 70 entrants, the Green Canvas was awarded first place in the sativa category for their Ambrosia strain. This year the Green Canvas was also awarded first place in the Sativa category at the Prairie Medicinal Harvest Cup for the 4th year in a row, achievements that the company is very proud of since the sativa strains typically take much longer to grow, and are often times more effective at treating the medical conditions of their patients.

As well, in September the Green Canvas joint venture announced that it submitted its application to become a licensed producer, and that they are in correspondence with Health Canada regarding specific quality assurance reports. Facility upgrades are ongoing and the construction progress can be seen in the aforementioned videos, highlighting just how close the company is to bringing the planned facility to fruition.

Tim Selenski is the head grower for the Green Canvas Ltd. grow team, and has worked with the Canadian government via their MMAR program for over 10 year time. Since its involvement in the MMAR program, Green Canvas has been widely covered in the Canadian media and has become a trusted source for medical marijuana patients.

Click For More Information:

– Company Website – http://www.enertopia.com/

– CannabisFN Profile Page – http://www.cannabisfn.com/mdc/enertopia-corp/

Legal Disclaimer:

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Enertopia and Lexaria Launch Medical Advisory Board

Posted by AGORACOM-JC at 8:04 AM on Thursday, November 20th, 2014

Vancouver, BC / November 20 2014 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce that it and joint venture partner Lexaria Corp (LXRP) have launched a formal Medical Advisory Board to educate and advocate on behalf of all those who have medical needs that may be able to be met through the understanding and use of medical marijuana or through the use of cannabidiol (CBD) extracted from Industrial Hemp.

The Medical Advisory Board members specialize in various medical categories, and will work with health care professionals, patients, and prescribers of medical marijuana to promote greater understanding of medical marijuana and of CBD-enhanced products. There are believed by many to be a wide variety of medical conditions that might be affected in a positive way either by medical marijuana or by CBD’s, but in many cases the accuracy of claims may not be well understood at this time.

In particular, the use of high-cannabidiol strains that have little or no psychoactive effects on the patient, are of interest for use to treat many medical symptoms, according to existing studies and literature.

Recreational use of Marijuana is illegal in Canada, and illegal at the federal level in the United States because of the THC content; and this status has prevented and or greatly reduced the opportunity for peer-reviewed scientific study. Still, there is growing evidence that there could be real medical benefits somehow associated with either medical marijuana and/or the CBD’s within it. Despite the hurdles to conducting past research, there are 1,277 references today to Cannabidiol at research papers located at the US National Library of Medicine, National Institutes of Health website (www.pubmed.gov).

Many organizations are calling for additional research regarding medical marijuana. For instance the Arthritis Society in September announced it wants more research to study the impact of medical marijuana on pain, and that it is preparing to fund clinical studies. Jason McDougall, chair of the Arthritis Society’s scientific advisory committee and a pain researcher at Dalhousie University was quoted at that time saying, “I think it’s high time that we found something to help the 4.6-million Canadians living with arthritis and trying to do something to help”.

Enertopia hopes to announce its first meetings and/or conferences as soon as possible in this sector and the wellness sector in general as the company moves forward.

Robert McAllister, Enertopia Corporation., President & CEO said, “We are all witnessing today the emergence of grass roots movement where the patient finally comes first in all aspects of wellness.”

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning the Advisory Medical Board. and any wellness opportunities and any positive impact on the Company, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The reader should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Montreal’s first medical marijuana clinic opens doors

Posted by AGORACOM-JC at 3:17 PM on Tuesday, November 11th, 2014

Clinic serves as portal to legal access to medical cannabis

CBC News Posted: Nov 11, 2014 12:42 PM ET Last Updated: Nov 11, 2014 12:42 PM ET

Palliative care expert Dr. Michael Dworkind will serve as medical director of Santé Cannabis.Palliative care expert Dr. Michael Dworkind will serve as medical director of Santé Cannabis.

The first medical marijuana clinic in Quebec has opened its doors in Montreal.

The goal of Santé Cannabis is to evaluate patients for therapies using medical marijuana, said Adam Greenblatt, the clinics’s executive director.

“There’s about one million patients across Quebec who medicate with cannabis in some way or another,” Greenblatt told CBC’s Daybreak.

“But the large majority of them access their cannabis from illicit unregulated sources. So our goal really is to help facilitate access to legal sources of medical cannabis to eligible patients who meet certain qualifications.”

Santé CannabisSanté Cannabis is in Montreal’s Gay Village neighbourhood. (Kate McKenna/CBC)

The name, Santé Cannabis, is a play on the French term for the federal government department, Santé Canada, (Health Canada).

‘The purpose of our clinic is to serve as a portal to legal access to medical cannabis. We know that the demand is out there’– Adam Greenblatt, Santé Cannabis

Greenblatt has enlisted Dr. Michael Dworkind as the clinic’s medical director, while Dr. Marcia Gillman will serve his associate director.

Both are known for their work in palliative care at Montreal’s Jewish General Hospital.

Greenblatt plans to have five doctors working in the clinic by February 2015.

Patients who come to the clinic are asked to have a referral from their family doctor or treating physician.

He said the clinic follows the guidelines set out by Quebec’s Collège des Médecins on the prescription of medical cannabis.

$250 annual fee

Greenblatt says Quebec’s medical insurance system will cover the cost of the consultation by one of the clinic’s doctors.

After that, patients will have to pay a $250 annual fee for the uninsured services of the clinic.

Those services include help choosing a licensed cannabis producer and an appropriate marijuana strain for treatment, and help navigating through the medical marijuana system.

Greenblatt says Santé Cannabis is a private business, but the main motivation is not profit.

“The purpose of our clinic is to serve as a portal to legal access to medical cannabis,” said Greenblatt. “We know that the demand is out there.”

Source: http://www.cbc.ca/news/canada/montreal/montreal-s-first-medical-marijuana-clinic-opens-doors-1.2831175

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

World of Marihuana Joint Venture Update

Posted by AGORACOM-JC at 6:29 PM on Friday, October 17th, 2014

VANCOUVER, BC / October 17, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) announces the following with respect to it’s Joint Venture partner World of Marihuana (“WOM”).

On October 14, 2014, WOM and the Company signed a Termination and Settlement Agreement with respect to the WOM Joint Venture (“JV”) Agreement previously disclosed, and entered into corresponding release agreements. The Company has relinquished it’s 31% interest in the JV back to WOM and has no further obligations under the JV. In consideration, WOM has returned 15,127,287 Enertopia common shares, which shares have been returned to treasury and cancelled. Further, Mathew Chadwick has resigned from the board of directors of the Company.

The Company will provide updates in the coming weeks with respect to its current facilities and outreach initiatives in the MMJ sector.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning updates in the coming weeks with respect to its current facilities and outreach initiatives in the MMJ sector, as well as expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Sanjay Gupta Discusses Possibilities, Challenges of Medical Marijuana

Posted by AGORACOM-JC at 9:47 AM on Thursday, October 9th, 2014
Dr. Sanjay Gupta at IOP

Dr. Sanjay Gupta, Chief Medical Correspondent at CNN, spoke about the potential of medical marijuana during an Institute of Politics forum event on Wednesday evening. The conversation was moderated by Dr. Staci Gruber, an Associate Professor of Psychiatry at Harvard Medical School.

 

CNN Chief Medical Correspondent Dr. Sanjay Gupta discussed the possibilities and challenges in expanding medical marijuana at the Institute of Politics on Wednesday.

The John F. Kennedy Jr. Forum event, moderated by Harvard Medical School associate professor Staci A. Gruber, comes just two days after the Harvard-affiliated McLean Hospital announced a “landmark new program” examining medical marijuana. The program will “explore the potential impact of medical marijuana on cognition, brain structure and function,” according to the announcement, and was funded by a $500,000 gift from best-selling crime writer Patricia Cornwell.

Gupta started off the conversation by discussing his “about-face,” referring to the well-known 2013 CNN column in which he apologized for misrepresenting marijuana to the American public.

“I realized that I had in my own way probably dismissed many patients as malingers who were just trying to get stoned,” Gupta said. “And there are a lot of those people. But there are also a lot of very, very legitimate patients as well for whom not only I realized that medical marijuana was working for them, it was working for them when nothing else had.”

He discussed how he afterwards looked at the evidence and found a “very distorted picture” of marijuana in the medical world, with a disproportionate number of studies “designed to find harm.” Gupta highlighted the stigma around supporting medical marijuana as a major challenge limiting scientific research on the topic.

Gruber then shared a clip from Gupta’s documentary “Weed,” highlighting the story of Charlotte Figi, a five-year-old suffering from severe epilepsy. Charlotte and her family had tried several toxic anti-epileptic drugs—but none of them worked, and Figi was still having around 300 seizures a week.

Medical marijuana was ultimately the solution to Figi’s condition, and, as Gupta emphasized, Figi’s story is “emblematic of [the story] of hundreds of families.”

Families like Figi’s, he pointed out, are “medical marijuana refugees”: they can now gain access to medical marijuana in Colorado but can lose their children and be put in prison for drug trafficking if they attempt to leave the state.

“I think it’s interesting to see how his viewpoint changed,” Zarin I. Rahman ’18 said. “Maybe we all need to be exposed to these families that he was, to maybe change our mind on this as well.”

Gupta repeated throughout the evening that the “policy has outpaced the science.” The states, he said, are moving forward without waiting for the science, and the issue is only compounded by the fact that the “policies and the laws we have in [the US] make it challenging for the science to get done.”

The important thing to do at this point in the legalization process, Gupta concluded, is to let marijuana, like any other medicine, “stand on its [own] merit scientifically.” When more scientific studies have been conducted, he said, when that “takes away some of the stigma surrounding this [issue], we can more easily get to the point where we can establish the thresholds” for marijuana use.

Source: http://www.thecrimson.com/article/2014/10/9/sanjay-gupta-medical-marijuana/

National Medical Marihuana Awareness and Outreach Strategy

Posted by AGORACOM-JC at 8:09 AM on Thursday, September 18th, 2014

 

VANCOUVER, BC / September 18, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce along with it’s Joint Venture partner Lexaria Corp that Maureen McGrath Host of the popular CKNW Sunday Night Sex Show and a registered nurse will be leading a National Medical Marihuana Awareness and Outreach Strategy.

Maureen specializes in reproductive and sexual health for men and women. She is in private practice both in North Vancouver and at Cross Roads Clinic in Vancouver where she see patients with sexual health issues.

Maureen’s background includes business development, advocacy and clinical research in the field of spinal cord injury as well as the biotechnical industry. A regular health contributor to radio and television, she is also a guest columnist for the 24Hours Newspaper.

Maureen is a sought after lecturer and routinely educates physicians, nurses, allied health, industry and the public on reproductive and sexual health and other quality of life issues. She is an invited guest lecturer an at the University of British Columbia and Simon Fraser University where she shares her knowledge base with undergraduate and medical students on bladder, bowel & sexual health.

Maureen is the Chair of the BC Chapter of Canadian Nurse Continence Advisors. Maureen is on the Board of the College of Midwives of British Columbia and on the Advisory Board for the Be More Than A Bystander Program with EVA BC and the BC Lions. She is a long time Mentor with Minerva’s “Women Helping Women Work” Program. Maureen is passionate about raising awareness about violence against women in homes, on the street and in the workplace.

As part of the national outreach plan, Maureen will be educating physicians, pharmacists, health care practitioners, and the public on the benefits and responsible use of medical marijuana for patients in need. Enertopia intends for Maureen to reach out via town hall – style meetings as well as through the media, and to build a network of people interested in the medical marihuana field for advocacy of the safe and therapeutic use of medical marihuana.

Further details of the National educational awareness campaign will be forth coming over the coming weeks.

“I am excited at the opportunity to help educate the health community on the potential benefits of Medical Marihuana and its many uses,” stated Maureen McGrath

Enertopia is very happy to welcome Maureen to our advocacy group for education and learning for physicians and patients in search of natural healing options.” Stated President / CEO Robert McAllister.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that Maureen McGrath will have any meaningful impact on doctor and patient awareness and or that the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: http://agoracom.com/portal/Small%20Cap%20Medical%20Ma

Enertopia Provides Burlington Lexaria JV Update

Posted by AGORACOM-JC at 8:11 AM on Wednesday, September 17th, 2014

VANCOUVER, BC / September 17, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) announces the Burlington, Ontario Application is in the Health Canada Preliminary Screening process.

The company is pleased to advise shareholders that its Joint Venture partner, Lexaria Corp (LXRP), and the Company have submitted their application for Licensed Producer in July 2014 and are in regular correspondence with Health Canada with respect to specific aspects of the licensing process, which are being handled by Ontario Operations Manager Mr. Donald Shaxon as responsible person in charge.

The Burlington Joint Venture with Lexaria Corp has applied to produce 10,000kg of Medical Marihuana per year under its Licensed Producer application. Enertopia has 51% interest in the joint venture and Lexaria Corp 49% as disclosed on April 9, 2014 in Enertopia’s press release #201424.

The Burlington JV has requested a Ready to build letter from Health Canada once the application has been accepted from Health Canada, see step 5 below.

For those not familiar with the Health Canada process for becoming a licensed producer, below are the levels to be reached through the application process. Note there are no specific process times for each step, however one could progress from preliminary screening to ready to build letter in as little as 90 to 120 days depending on the application submitted to Health Canada:

Step 1: Preliminary Screening
Step 2: Enhanced Screening
Step 3: Security Clearance
Step 4: Review
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Step 7: Licensing

The Joint Venture (JV) has been active in the local community and has received very good community and media support. The JV also met with the local policing authority and upon licensing by Health Canada we have proposed that the local police could conduct security and swat team training at the facility. We are very pleased to be working closely with law enforcement and look forward to their insights in preventative and proactive security measures.

Enertopia at this time publically acknowledges its support for the Lexaria Corp policy on the responsible use of medical marijuana announced on August 28, 2014. Therefore, Enertopia is establishing a corporate policy wherein we will not knowingly sell medical cannabis containing more than 0.3% THC to any medical marijuana patient who is under the age of 21, unless it is in a form specifically approved by relevant government health agencies.

“Enertopia’s overriding responsibility is to cause no harm and keep Medical Marijuana as a safe and secure option for patients in search of natural healing options.” Stated President / CEO Robert McAllister.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential licensing and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Burlington Joint Venture will obtain a license under MMPR and or that the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Enertopia Provides Update on The Green Canvas JV

Posted by AGORACOM-JC at 8:04 AM on Tuesday, September 16th, 2014

VANCOUVER, BC / September 16, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) Green Canvas Application is in the Health Canada preliminary screening process.

The company is pleased to advise shareholders that it has been informed by its Joint Venture partner The Green Canvas that they have submitted their application for Licensed Producer and are in correspondence with Health Canada with respect to specific aspects of Quality Assurance Reports which are being handled by their in house PH.D in Organic Chemistry in the application process.

The Green Canvas has applied to produce 10,000 kg of Medical Marihuana per year under its Licensed Producer application. Enertopia may acquire up to a 75% interest in the joint venture as disclosed on February 28, 2014 in our press release 201412.

Facility upgrades are ongoing and Enertopia’s Management team will be onsite in early October and will provide a project update shortly thereafter.

For those new to the Health Canada process for becoming a licensed producer below are the levels to be reached through the application process, Note there are no specific process times for each step:

Step 1: Preliminary Screening
Step 2: Enhanced Screening
Step 3: Security Clearance
Step 4: Review
Step 5: Ready to build letter (if required by applicant)
Step 6: Pre-licence inspection
Step 7: Licensing

“The Green Canvas is well known and respected in their outreach to patients in need of Medical Marihuana and are respected for producing the highest quality of medical grade marihuana.” Stated President / CEO Robert McAllister.

Further information on the Green Canvas can be found at www.thegreencanvas.ca/

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Green Canvas Joint Venture will obtain a license under MMPR and or that the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Smoking hot marijuana stocks could give investors a buzz

Posted by AGORACOM-JC at 11:41 AM on Tuesday, September 2nd, 2014
Dilys Chan, BNN.ca staff
10:53 AM, E.T. | August 30, 2014
Canadian, Energy & Resources

It’s an exciting time for medical pot in Canada. Two new licensed medical marijuana companies started trading on Monday: OrganiGram Holdings Inc. (OGI.V 2.27 0.02 0.89%) and Bedrocan Cannabis Corp. (BED.V 1.12 0.04 3.7%). They joined Tweed Marijuana Inc. (TWD.V 2.45 -0.02 -0.81%) on the TSX Venture Exchange, bringing the total number of publicly traded marijuana stocks in Canada to three. Both of the new stocks ended the week above their opening prices.

The trend in the commodities space will continue with a fourth company, Mettrum, to hold an IPO in September. According to Khurram Malik, a research analyst at Jacob Securities, the fledgling licensed marijuana industry is at very early stages of enormous growth.

“The [companies] on the Venture exchange with licenses – they’re going to go from $0 to $10 million in revenue pretty quickly in the next year. Tweed’s a perfect example. They’ll have 12 grow rooms up and running by the end of the year,” said Malik.

“The question over the next few months is how quickly suppliers can get their act together and start getting their supply in the market. It is a bit tricky to produce marijuana at a large scale.”

Producers who can ramp up capacity, production and revenue quickly enough can tap into a target market that could potentially generate $1.8 billion in annual revenue, he said to BNN.

The cannabis plant can be a legitimate treatment option for over 100 ailments, said Malik, with pain relief being a common use. With an estimated 500,000 medical pot users in Canada and only 13 suppliers licensed by Health Canada, there is significant demand for product.

“These are very profitable investments for investors to be getting exposure to,” he said.

Investors can compare two key metrics of companies as the industry matures, Malik said. The first is cost to grow product, measured in dollar per gram. The second is how effectively the company acquires customers, a metric that will become more important as producers seek to differentiate themselves from their competition.

Ultimately, Malik thinks marijuana will be legalized, though it’s unclear when that will happen. In the meantime, a regulatory challenge for producers is that they can’t market directly to the consumers or open storefronts. Potential customers need a medical document, similar to a prescription, which then allows them to choose a supplier. But, they have to research and find the supplier on their own. The industry depends on its consumers being self-educating.

Despite that inconvenience, Malik isn’t worried about demand being low for medical pot.

“Buying from the legitimate producers is cheaper, it’s a higher quality and it’s more convenient than going to your proverbial street corner and buying it black market at twice the price.”

Source: http://www.bnn.ca/News/2014/8/30/Smoking-hot-marijuana-stocks-could-give-investors-a-buzz.aspx

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Enertopia Makes Steady Progress as Industry Heats Up

Posted by AGORACOM-JC at 10:33 AM on Monday, August 25th, 2014

WHITEFISH, MT / August 25, 2014 / Canada’s Marihuana for Medical Purposes Regulations (“MMPR”) program has been mired in controversy since the beginning. After switching from the Medical Marihuana Access Regulations (“MMAR”) to the MMPR program in October 1, 2013, Personal Use Production Licenses (“PUPL”) and Designated Person Production Licenses (“DPPL”) were phased out on March 31, 2014.

The transition from the MMAR to the MMPR program was designed to move marijuana production out of homes and into tightly regulated corporations. Unfortunately, these dynamics translated to an immediate increase in costs for many medical marijuana patients, which led to lawsuits against Health Canada to permit home growing until a better plan was established.

In the meantime, Health Canada has approved 13 licensed producers under the MMPR program that have already begun selling product. These sales are likely to accelerate as the new MMPR program picks up steam, with the government projecting about $1.3 billion per year in revenue by 2024, while home growing operations are likely to end in the near-term following the court resolutions.

Industry Heating Up

The large potential market for licensed producers under the MMPR program has led to tremendous investor interest in the space. With four licensed producers undergoing transactions to become publicly traded, including OrganiGram Inc. (TSX-V: OGI), Mettrum Ltd., Bedrocan Canada Inc., and PharmaCan Capital, investors will have the ability to invest directly or indirectly in seven of the 13 licensed producers.

Tweed Marijuana Inc. (TSX-V: TWD) (OTC: TWJMF) was the first publicly traded licensed producer and has already achieved a market capitalization of over $100 million, as of August 2014. Many private licensed producers have also reported rising demand from fund managers and venture capital firms looking for a piece of the action, signaling investor confidence in the MMPR’s ultimate success.

With many of these publicly traded companies already reaching $50 to $100 million valuations, investors may want to take a look at promising aspiring licensed producers that may be trading at a discount. Diversification across several companies that are approved and/or seeking approval may be the best way to reduce risk in a sector that is characterized by its high volatility.

Making Steady Progress

Enertopia Corp. (OTC: ENRT), with a market cap of only $10.6 million, is an aspiring licensed producer under Canada’s MMPR program that sets itself apart from the competition. With extensive experience under the prior MMAR program, the company has experience growing and handling medical marijuana, unlike many other newer applicants, and regulators know they can trust the firm to deliver on its promises.

CannabisFN Executive Interview | Enertopia Corp. (OTCQB: ENRT) from TDM Financial on Vimeo.

The company’s three major projects are all making steady progress. Security upgrades are being installed at the Green Canvas project in Saskatchewan; design upgrades are in the works at the GTA project in Ontario in partnership with Lexaria Corp. (OTC: LXRP); and, the World of Marijuana project is awaiting its Health Canada site visit as the government continues to work through its backlog.

The company is also actively pursuing opportunities to diversify into related areas like oils, edibles, and industrial hemp markets across North America. Management hopes that these efforts to establish multiple revenue streams will reduce risk for investors and ultimately help internally finance its growth. These efforts also set the company apart from many other pure-plays in the space.

Looking Ahead

Canada’s medical marijuana space may have had a rough start, but the MMPR program appears to be picking up steam. As Health Canada’s site visits take place, many companies are also becoming acquisition targets, as evidenced by Tweed’s acquisition of Park Lane Farms following its approval earlier this month. These dynamics could justify even higher valuations for smaller firms in the space.

Enertopia has a key advantage with its MMAR operating history and experienced management team. As it continues to progress towards licensure, investors in the marijuana space may want to take a second look, including those involved with U.S.-based companies like Medical Marijuana Inc. (OTC: MJNA) or Hemp Inc. (OTC: HEMP), given Canada’s more established federal-level programs.

For more information, see the following resources:

– Company Website – http://www.enertopia.com/

– CannabisFN Profile – http://www.cannabisfn.com/mdc/enertopia-corp/

Sign Up For Future Email Updates On Enertopia Corp.

http://www.tdmfinancial.com/emailassets/enrt/enrt_landing.php

Disclaimer: Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

SOURCE: Emerging Growth LLC

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks